Walleye Capital
SNY icon

Walleye Capital’s Sanofi SNY Stock Holding History

Walleye Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Sell
29,000
-120,700
-81% -$5.63M 0.01% 1770
2025
Q4 		$7.25M Buy
149,700
+50,000
+50% +$2.48M 0.02% 866
2025
Q3 		$4.71M Buy
99,700
+70,900
+246% +$3.42M 0.02% 954
2025
Q2 		$1.39M Buy
28,800
+17,000
+144% +$869K 0.01% 1796
2025
Q1 		$654K Sell
11,800
-35,000
-75% -$1.89M ﹤0.01% 2331
2024
Q4 		$2.26M Sell
46,800
-3,100
-6% -$158K 0.01% 1674
2024
Q3 		$2.88M Buy
49,900
+26,800
+116% +$1.45M 0.01% 1617
2024
Q2 		$1.12M Buy
23,100
+20,200
+697% +$974K ﹤0.01% 2721
2024
Q1 		$141K Sell
2,900
-72,400
-96% -$3.54M ﹤0.01% 4190
2023
Q4 		$3.74M Sell
75,300
-8,700
-10% -$425K 0.01% 1294
2023
Q3 		$4.51M Buy
84,000
+39,700
+90% +$2.12M 0.01% 1105
2023
Q2 		$2.39M Buy
44,300
+42,700
+2,669% +$2.3M 0.01% 1210
2023
Q1 		$87.1K Buy
+1,600
New +$77.8K ﹤0.01% 3007

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Walleye Capital's SNY Position: Q1 2026 in Review

Walleye Capital increased its Sanofi (SNY) stake by 441,700% in Q1 2026, buying an estimated $206K and bringing the position to 4,418 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #3311.

Walleye Capital first reported a position in SNY in Q3 2018 and has held it in 11 quarters since. The position peaked at $9.38M in Q3 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Walleye Capital held 4,418 shares of Sanofi worth $213K as of Q1 2026.
  • Walleye Capital bought 4,417 Sanofi shares in Q1 2026, an estimated $206K.
  • Sanofi made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3311 holding.
  • Walleye Capital first reported a position in Sanofi in Q3 2018 and has held it in 11 quarters since.
  • Walleye Capital's Sanofi position peaked at $9.38M in Q3 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.